ALung Technologies recently announced the initiation of patient enrollment in its VENT-AVOID trails with the Minneapolis Heart Institute Foundation. The trial is pivotal in validating the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients who require ventilatory support.
Recent Posts
Meet the Executive: Brent Burns, Executive Vice President
Over the last two decades, Brent Burns has worked in the ever-changing technology and health space. As an executive at UPMC Enterprises, he draws upon his prior experiences every day.
Read More →
A look back at HIMSS 2019
With HIMSS ’19 wrapped up, we reflect on our experiences and learnings from our time in sunny Orlando, Fl.
Read More →
Vivify Health debuts BYOD remote monitoring tech, talks FHIR at HIMSS19
Vivify Health, a UPMC Enterprises portfolio company, debuted their newest product offering last week at …
Read More →